Rasagiline Mesylate in Patients With Multiple System Atrophy of the Parkinsonian Subtype

- Multiple System Atrophy
- Completed

Study Title: Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

Teva Identifier: MSA-RAS-202 | 2009-014644-11

ClinicalTrials.gov Identifier: NCT00977665

Study Status: Completed

Trial Condition(s): Multiple System Atrophy

Interventions: Drug: rasagiline mesylate | Drug: placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 30 Years and older

Trial Duration: 12/01/2009 - 10/01/2011

Phase: Phase 2

Study Type

Interventional